Immunology is the study of the immune system and its functions.
免疫学是研究免疫系统及其功能的学科。
The vaccine stimulates an immune response against the virus.
疫苗能刺激针对病毒的免疫反应。
Autoimmune diseases occur when the body's immune system attacks its own tissues.
自身免疫疾病发生时，身体的免疫系统会攻击自身的组织。
Immunodeficiency disorders leave individuals vulnerable to infections.
免疫缺陷病使得个体易受感染。
Transplant rejection is a result of the recipient's immune system recognizing the transplanted organ as foreign.
移植排斥是因为接受者的免疫系统将移植器官识别为外来物。
Antibodies are proteins produced by the immune system to neutralize pathogens.
抗体是免疫系统生成的蛋白质，用于中和病原体。
Allergies occur when the immune system overreacts to a harmless substance, like pollen or peanuts.
过敏症发生在免疫系统对花粉或花生等无害物质过度反应时。
Immunosuppressive drugs are used to prevent rejection in organ transplant patients.
免疫抑制药物用于防止器官移植患者的排异反应。
The study of
immunology helps us understand how the body fights off infections and cancer.
免疫学的研究帮助我们理解身体如何抵抗感染和癌症。
Infectious diseases can sometimes trigger autoimmune conditions due to a malfunction in the immune system.
感染性疾病有时会由于免疫系统的功能失调而引发自身免疫病。
In the realm of healthcare innovation, AbbVie showcased a versatile array of pioneering products across five key focuses of areas, including immunology, oncology, eye care, neuroscience, and aesthetics.
在医疗保健创新领域，AbbVie展示了涵盖免疫学、肿瘤学、眼部护理、神经科学和美学等五个关键领域的一系列创新产品。
Moreover, Ozurdex, a treatment of retinal diseases, will be on display at the CIIE, while Skyrizi, a standout product in immunology, and Epkinly, a hematological tumor solution, will make their "China debut" at the event.
此外，治疗视网膜疾病的Ozurdex将在CIIE展出，而免疫学领域的杰出产品Skyrizi和血液肿瘤解决方案Epkinly将在活动中“首次亮相”。
GSK will showcase its key advances and innovative capabilities in research and development in core therapeutic areas: infectious diseases, immunology and respiratory diseases, oncology, and HIV.
葛兰素史克将展示其在核心治疗领域研发的关键进展和创新能力：传染病、免疫学和呼吸系统疾病、肿瘤学和艾滋病毒。
We have made significant progress in transforming Novartis into a focused pharmaceutical company working in five core therapeutic areas — cardiovascular, immunology, neuroscience, solid tumors and hematology — to bring high-value innovation to patients," said Aradhye.
Aradhye说：“我们在将诺华转变为一家专注于心血管、免疫学、神经科学、实体瘤和血液学五个核心治疗领域的制药公司方面取得了重大进展，为患者带来了高价值的创新。”。
Regarding this year's public welfare program, He Xuzheng, vice-president of Janssen China's Immunology and Pulmonary Hypertension Department, said: "As an innovative pharmaceutical company which entered the Chinese market 38 years ago, Janssen has been always committed to providing Chinese patients with high-quality, innovative products.
关于今年的公益计划，杨森中国免疫与肺动脉高压部副总裁何旭正表示：“作为一家38年前进入中国市场的创新制药公司，杨森一直致力于为中国患者提供高质量、创新的产品。
The company made its debut at the recently concluded fifth China International Import Expo, showcasing several medicines covering neurology, immunology, bone health and rare diseases.
该公司在最近结束的第五届中国国际进口博览会上首次亮相，展示了涵盖神经病学、免疫学、骨健康和罕见病的几种药物。
"UCB will continue to strengthen our portfolio in neurology, expand our innovative pipeline in immunology, and provide solutions for rare neurological and immunological diseases for which treatments are currently very limited," said Wu Xin, UCB China's general manager.
UCB中国区总经理吴昕表示：“UCB将继续加强我们在神经病学方面的投资组合，扩大我们在免疫学方面的创新渠道，并为目前治疗非常有限的罕见神经和免疫疾病提供解决方案。”。
US-based pharmaceutical company Bristol Myers Squibb has brought 12 innovations in the areas of oncology, hematology, and immunology to the ongoing 5th China international Import Expo and will continue to help patients with unmet needs in China by introducing up to 30 innovative medicines or indications by 2025, said its China president.
总部位于美国的百时美施贵宝制药公司中国总裁表示，该公司已将肿瘤学、血液学和免疫学领域的12项创新成果带到正在举行的第五届中国国际进口博览会上，并将在2025年前推出多达30种创新药物或适应症，继续帮助中国需求未得到满足的患者。
The company will also step up independent new product research and development in China while licensing in pipelines through strategic cooperation with other drug developers, shared Lin, who is also head of the respiratory, gastrointestinal and immunology business unite of AstraZeneca China.
同时也是阿斯利康中国呼吸、胃肠和免疫学业务部门负责人的林表示，该公司还将加强在中国的独立新产品研发，同时通过与其他药物开发商的战略合作获得管道许可。
Jean-Christophe Pointeau, president of China Pfizer Biopharmaceutical Group, said that Cibinqo is the group's globally ground-breaking innovative product in inflammation and immunology, and a crucial part of its dermatology strategic planning in China.
中国辉瑞生物制药集团总裁Jean-Christophe Pointeau表示，Cibinqo是该集团在炎症和免疫学领域的全球突破性创新产品，也是其在中国皮肤科战略规划的重要组成部分。
未经许可，严禁转发。QQ交流群：688169419